| ORGANISATION | PROJECT NAME | DRUG | PHASE | TARGET COMPLETION | NCT NUMBER |
| Abbvie | ABBV-951 | LD/CD | 3 | March 2021 | 03781167 |
| Mitsubishi Tanabe/Neuroderm | ND0612 | LD/CD | 3 | April 2021 | 04006210 |
| Rennes University | EARLY-PUMP | Apomorphine | 3 | March 2023 | 02864004 |
| US WorldMeds | INFUS-ON | Apomorphine | 3 | September 2021 | 02339064 |
| Mitsubishi Tanabe/Neuroderm | ND0701 | Apomorphine | 1 | N/A | N/A |
| Dizlin | Infudopa | LD/CD | 1 | Early 2020 | 03419806 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.